identifeye HEALTH’s Post

The number of people over the age of 40 living with diabetes-related eye disease has more than doubled during the last two decades, according to a study cited by Ophthalmology Times. “The information provided in this study can be used at the national, state, and county level to understand the burden of diabetic retinopathy and to design interventions to help people living with the condition preserve their vision,” said David B. Rein, PhD, one of the study’s co-authors. Learn more here: https://hubs.la/Q026672P0 #DigitalDiagnostics #LumineticsCore #Healthcare #Diabetes

Regular retinal screening, also known as diabetic retinopathy screening, can lead to reduced healthcare risks in individuals with diabetes. Diabetic retinopathy is a common complication of diabetes that affects the blood vessels in the retina, the light-sensitive tissue at the back of the eye. This condition can lead to vision loss or blindness if left untreated. Here are some ways in which an OxIA screening can reduce healthcare risks: Early Detection: Retinal screening allows for the early detection of diabetic retinopathy. When the condition is identified in its early stages, treatment and management can be initiated promptly, reducing the risk of progression to more severe forms of the disease. Preventing Vision Loss: By identifying diabetic retinopathy and other eye conditions early, healthcare providers can implement interventions such as laser therapy, injections, or surgery to prevent or slow down vision loss. This can greatly reduce the healthcare risks associated with blindness and its associated costs, including rehabilitation and long-term care. Monitoring Disease Progression: Regular retinal screenings provide a way to monitor the progression of diabetic retinopathy and adjust treatment plans accordingly. This ongoing assessment helps prevent the development of advanced stages of the disease and minimizes the associated healthcare risks. Improving Quality of Life: Preserving vision through early intervention and treatment not only reduces healthcare costs but also improves an individual's quality of life. Maintaining vision allows for greater independence, mobility, and overall well-being. Reducing Burden on Healthcare System: Preventing severe vision loss due to diabetic retinopathy reduces the burden on the healthcare system by decreasing the number of patients requiring extensive eye care, rehabilitation, and long-term support services. Enhancing Diabetes Management: Regular retinal screening is an essential component of diabetes management. When individuals are aware of their risk for diabetic retinopathy, they are more likely to adhere to their diabetes management plan, including blood sugar control and lifestyle modifications. Cost Savings: Preventing vision loss through retinal screening can result in significant cost savings for both individuals and healthcare systems. In summary, regular OxIA screenings for individuals with diabetes can lead to early detection and treatment of diabetic retinopathy, reducing the risk of vision loss and associated healthcare costs. It plays a crucial role in preserving vision, improving quality of life, and lessening the burden on the healthcare system. We invite you to engage with us and learn more about how OxIA can make a difference for healthcare professionals and patients. #OxIA #GeneralPractitioners #Physicians #Ophthalmologist #Opticians #Optometrists #EarlyDetection #PreventingVisionLoss #DiabetesAwarenessMonth #DiabeticRetinopathy

As we observe Diabetic Awareness month in November we aim to highlight the importance of regular retinal screenings. We extend an invitation to all healthcare professionals with a strong commitment to diabetic patient care. Join us in learning more about OxIA and the advantages our screening platform brings to both your patients and your healthcare practice in their care. You can contact me on lydia@oxia.org or 0824990397 #OxIA #DiabeticAwarenessMonth #DiabeticCare #RetinalScreenings #DiabeticRetinopathy

https://lnkd.in/ePg8-8Pb Article title: Corneal Diabetes: Where to Next?   Author(s): Karamichos Dimitrios*   Journal: Journal of Clinical Research and Ophthalmology   Journal ISSN: 2455-1414 Editorial: Diabetes mellitus (DM) or better known as simply diabetes is a group of metabolic diseases in which high blood sugar levels are maintained over a prolonged period. Long term complications include but not limited to heart disease, stroke, kidney failure, and ocular damage. There are two main types of diabetes: Type I (T1DM) and Type II (T2DM). In 2013, an estimated 382 million people were diagnosed with diabetes with type 2 accounting for 90% of the cases. Unfortunately, to date, despite significant amount of research there is no known cure except in very specific cases. #Cornea #Diabetes #InVitro #InVivo #OphthalmologySubspecialties #Optometry #VisualScience #PharmacologyInEyeDiseases #BasicSciences #PrimaryEyeCare #SecondaryEyeCare #PatientSafety #QualityImprovements #NeuroOphthalmology #MedicalEyeCare #SurgicalEyeCare #GlaucomaFilteringProcedure #OcularDrugDesign #ClinicalPsychophysics #DiabeticRetinopathy #CataractSurgery #RefractiveSurgery #PVRStudies #LowVision #PterygiaStudies #PupilLightReflex #Peertechz #PeertechzPublications #SecondaryCataractStudies #RetinalDiseases #RetinalSurgery #SubstancePStudies #Cornea #ExternalEyeDisease #DefensinsForCorneaTransplants #CraniofacialClinic #OptometryClinic #OphthalmicGeneticsClinic #NeuroOphthalmologyClinic #Oculoplastics #TearingDisordersClinic #PediatricRetinaClinic #CornealNeovascularization #ImmunologicalMechanisms #MolecularMechanisms #LaserTherapyInOphthalmology #ImagingInOphthalmology #OcularImmunology #VisionAndOphthalmology #NeuroOphthalmology

https://lnkd.in/g5R5YRPs                                                                                            Article title: Rheumatoid Arthritis and Acute Coronary Syndrome: Changing Clinical Presentation   Author(s): HS Natraj Setty*, Rahul S Patil, Sumit Bhatnagar, Animesh Guptha, TR Raghu, Jayashree Kharge, BK Geetha, CN Manjunath Journal: International Journal of Vascular Surgery and Medicine   Journal ISSN: 2455-5452 Abstract: Rheumatoid arthritis is a chronic systemic inflammatory disease, Rheumatoid arthritis can affect the pericardium, myocardium, and endocardium. RA increases cardiovascular morbidity and mortality by accelerated atherosclerosis. Patients with RA are at a twofold increased risk for myocardial infarction and stroke. Rheumatoid arthritis is often complicated by thrombocytosis. Thrombocytosis usually occurs during the active clinical stages of RA. We report a 40 year old male who presented with sudden onset of back pain, neck pain and gum bleeding he was diagnosed to have Acute Anterior Wall Myocardial Infarction (AWMI) and successfully under went PCI to LAD with uneventful follow up. #RheumatoidArthritis #AcuteCoronarySyndrome #PCI #Angiology #BiochemistryOfBloodFluids #DiseasesOfTheCirculatorySystem #DiseasesOfTheLymphaticSystem #ArterialThrombosisAndEmbolism #Vasculitides #VasospasticDisorders #VenousDiseases #VenousThrombosis #ChronicVenousInsufficiency #VaricoseVeins #LymphaticDiseases #Lymphedema #BloodVesselFormation #HighBloodPressure #BloodAndHypertension #HeartAttack #BloodVesselPathology #Vasoconstriction #VascularImaging #VascularClots #AbdominalAorticAneurysms #Peertechz #PeertechzPublications #BlockageOfBloodVessels #CarotidEndarterectomy #BypassSurgeryForLegArteries #GangreneManagement #RoboticVascularSurgery #AortoIliacDisease #AorticAneurysmSurgery #AorticOcclusionSurgery #EmergencyVascularSurgery #VascularControl #TumorEmbolisation #VaricoseVeinsTreatment #LegUlcersTreatment #VascularDiseaseTreatment #MetabolicDisorders #ArterialOcclusiveDisease #AneurysmalDisease #LymphaticDisorders #ArterialDisease #VenousDisease #PulmonaryDisease #Cardiovascular #Neurovascular #Cerebrovascular #CerebralVascularDisease #VascularDiseaseSymptoms #PeripheralVascularDiseaseSymptoms #PeripheralVascularDiseaseTreatment #CarotidVascularDisease #RenalVascularDisease #HypertensiveVascularDisease #VascularHeartDisease #CollagenVascularDiseaseSymptoms #ArterioscleroticVascularDisease #CardiovascularDiseasePrevention #CirculatoryDiseases #CoronaryVascularDisease

📍 Testosterone Treatment and Fractures in Men with Hypogonadism January 18, 2024. 🔸 #Testosterone didn’t lower fracture risk in a surprising new study. Excerpt: A subtrial of the phase 4 TRAVERSE trial revealed testosterone treatment was not associated with a reduction in the incidence of clinical fractures, compared with placebo, among middle-aged and older men with #hypogonadism. The findings showed the 3-year cumulative incidence of all clinical fractures was nearly 4% among those treated with testosterone, compared with 2.8% in the placebo group. Further data revealed the fracture incidence was also numerically greater in the testosterone group for all other fracture endpoints. “We did not expect these results, because most previous studies showed that testosterone improved many measures of bone structure and quality,” wrote the investigative team, led by Peter J. Snyder, MD, Perelman School of Medicine, University of Pennsylvania. The TRAVERSE phase 4 trial, designed to address whether testosterone treatment would increase the incidence of major adverse cardiovascular events in middle-aged and older men, provided an opportunity to address whether testosterone treatment would reduce the risk of clinical fractures. Testosterone treatment among men with hypogonadism, due to pituitary or testicular disease, or aging, has been reported to improve several bone density and quality measures. However, severe hypogonadism has been linked to an increased risk of clinical fractures among men with prostate cancer. Thus, a trial with a sufficiently large sample and long duration could benefit the understanding of the effect of testosterone therapy on fracture incidence. Median testosterone levels in the testosterone cohort increased from 227 ng per deciliter at baseline to 368 ng per deciliter at month 6 and sustained a higher level than baseline through year 3. On the other hand, the placebo cohort did not experience a substantial change in the median serum testosterone cohort. Further safety analyses revealed testosterone was not associated with a higher risk of major adverse cardiovascular events, but treatment was #associated with an #increased #risk of atrial fibrillation, pulmonary embolism, and acute kidney injury. With the findings unexpected, the trial was not designed to assess mechanisms that might explain an increase in fractures, such as changes in bone density and structure. In editorial researchers further explain "Instead, testosterone's behavioral effects may have put patients at a higher risk for fracture. "Testosterone might have affected behaviors such as engaging in physical activities associated with fracture risk," they speculated ➡ https://lnkd.in/e77ETtND . ➡ Reference: https://lnkd.in/eaSgfFPq ➡ https://lnkd.in/e9rJidgT #hypogonadalman #menshealth #HRTinman

Our latest article on the Safety and Efficacy of Brolucizumab in treating Diabetic Macular Edema and Diabetic Retinopathy! Our systematic review and meta-analysis found significant improvement in visual acuity and macular thickness with brolucizumab, which was either better or non-inferior to other anti-VEGF treatments. The study also found the treatment to be relatively safe in diabetic patients, with few adverse events observed. Do read if you have time!! https://lnkd.in/d2m2NERF #AntiVEGF #Brolucizumab #Ophthalomology #EyeDisease #Vision #VisionLoss #DME #DiabeticRetinopathy #EyeDrug #Treatment #RetinalDiseases

Research led by the Cleveland Clinic in Florida shows that rates of diabetic retinopathy are increasing, most rapidly in younger people and in Black and Hispanic populations. Diabetic retinopathy, a vascular disorder affecting the retina in the eye, is a significant cause of blindness in the U.S. Anyone with diabetes, type 1, type 2 or even less common types such as gestational diabetes, can develop retinopathy as a complication of their condition. A paper published in 2021 suggests that just over a quarter of people with diabetes (around 9.6 million people) in the U.S. have diabetic retinopathy and, of these, around a fifth have sight threatening disease. The current study, published in JAMA Ophthalmology, looks at how rates of diabetic retinopathy changed between 2015 and 2022 in the U.S. The cross-sectional study used data from the TriNetX Analytics health research network including 56 health care organizations and 359,126 people with type 1 or type 2 diabetes and retinopathy. Overall, prevalence of retinopathy associated with type 1 diabetes increased by 15 percent and with type 2 diabetes by seven percent between 2015 and 2022. However, lead author Rishi Singh, vice president and chief medical officer, Cleveland Clinic Martin North and South Hospitals, and colleagues noted significant differences between population groups. #diabeticretinopathy #minoritycommunities #👍👍

https://lnkd.in/gebh5pcT                                                                                       Article title: The use of Cilostazol in Diabetic Patients   Author(s): Konstantinos Spanos* and Athanasios D Giannoukas Journal: International Journal of Vascular Surgery and Medicine   Journal ISSN: 2455-5452 Editorial: The International Diabetes Federation (IDF) reported that the global prevalence of diabetes (DM) in adults was 8.3% in 2013 expecting to rise beyond 592 million by 2035 with a 10.1% global prevalence [1]. Guidelines have been published for the treatment of this major disease and its complications [2,3]. #Angiology #BiochemistryOfBloodFluids #DiseasesOfTheCirculatorySystem #DiseasesOfTheLymphaticSystem #ArterialThrombosisAndEmbolism #Vasculitides #VasospasticDisorders #VenousDiseases #VenousThrombosis #ChronicVenousInsufficiency #VaricoseVeins #LymphaticDiseases #Lymphedema #BloodVesselFormation #HighBloodPressure #BloodAndHypertension #HeartAttack #BloodVesselPathology #Vasoconstriction #VascularImaging #VascularClots #AbdominalAorticAneurysms #Peertechz #PeertechzPublications #BlockageOfBloodVessels #CarotidEndarterectomy #BypassSurgeryForLegArteries #GangreneManagement #RoboticVascularSurgery #AortoIliacDisease #AorticAneurysmSurgery #AorticOcclusionSurgery #EmergencyVascularSurgery #VascularControl #TumorEmbolisation #VaricoseVeinsTreatment #LegUlcersTreatment #VascularDiseaseTreatment #MetabolicDisorders #ArterialOcclusiveDisease #AneurysmalDisease #LymphaticDisorders #ArterialDisease #VenousDisease #PulmonaryDisease #Cardiovascular #Neurovascular #Cerebrovascular #CerebralVascularDisease #VascularDiseaseSymptoms #PeripheralVascularDiseaseSymptoms #PeripheralVascularDiseaseTreatment #CarotidVascularDisease #RenalVascularDisease #HypertensiveVascularDisease #VascularHeartDisease #CollagenVascularDiseaseSymptoms #ArterioscleroticVascularDisease #CardiovascularDiseasePrevention #CirculatoryDiseases #CoronaryVascularDisease

https://lnkd.in/eSaB8rhW Article title: Association of ulcerative colitis and IgA nephropathy: A case report   Author(s): S Boulajaad*; M Haida; Ait Errami; S Oubaha; Z Samlani; K Krati   Journal: Global Journal of Medical and Clinical Case Reports   Journal ISSN: 2455-5282 Abstract: The extradigestive manifestations of chronic inflammatory bowel disease most often affect the articulations, skin, eyes, liver and bile ducts. Renal involvement is rare, and manifests as kidney stones, glomerulonephritis, tubulointerstitial nephritis, and secondary amyloidosis. In this context of chronic inflammatory bowel disease, in particular ulcerative colitis, renal involvement is very often secondary to nephrotoxicity of the basic treatment of digestive pathology, and very rarely an authentic extradigestive manifestation of intestinal disease. #UlcerativeColitis #IgANephropathy #ExtradigestiveManifestation #IBD #ForensicMedicine #ExperimentalMedicine #PediatricEmergencyMedicine #IntegrativeMedicine #AlternativeMedicine #EmergencyMedicine #GenomicMedicine #TranslationalMedicine #PulmonaryAndRespiratoryMedicine #TropicalMedicine #AddictionTherapy #Anatomy #AncientDiseasesAndPreventiveRemedies #BloodDisorders #HealthEducation #BoneMarrowTransplantation #Cloning #Hypertension #Leukemia #MycobacterialDiseases #OralHealth #TreatmentOfTrauma #AllergyAndClinicalImmunology #CancerResearchAndClinicalOncology #TranslationalOncology #ClinicalAndExperimentalNephrology #ClinicalChildPsychology #PsychotherapyAndPsychiatry #ClinicalChiropractic #ClinicalDensitometry #ClinicalEndocrinologyAndMetabolism #ClinicalEpidemiology #ClinicalGastroenterologyAndHepatology #ClinicalAndExperimentalOphthalmology #Pathology #ClinicalAndExperimentalOptometry #ClinicalAndExperimentalOtorhinolaryngology #Otolaryngology #Peertechz #PeertechzPublications #OpenAccess #ScientificJournals #PeerReviewedJournals #OpenAccessPublishers #ClinicalAndExperimentalPharmacologyAndPhysiology #ClinicalAnesthesiology #Anesthesia #ClinicalHypertension #AppliedThrombosis #ClinicalAndExperimentalAllergy #Dermatology #OralInvestigations #ClinicalOrthopaedics #ClinicalPathology #MolecularPathology #ClinicalMetastasis #Apheresis #ClinicalBiochemistryAndNutrition #Biomechanics #ClinicalCardiology #ClinicalGeneticsAndHematology #ClinicalInterventionsInAging #ClinicalLaboratoryAnalysis #ClinicalLinguistics #Phonetics #ClinicalLipidology #ClinicalMicrobiology #Antimicrobials #InfectiousDiseases #ClinicalMonitoringAndComputing #ClinicalNeurology #Neurosurgery #Neurophysiology #Neuropsychology #Neuroradiology #Neuroscience #ClinicalPharmacology #Toxicology #PharmacyAndTherapeutics #ClinicalPhysiology #ClinicalImaging #FunctionalImaging #ClinicalRadiology #ClinicalRehabilitation #ClinicalRespiratory #ClinicalRheumatology #ClinicalTherapeutics #ClinicalTrials #ClinicalTransplantation #ClinicalUltrasound #ClinicalVirology #TherapeuticsAndClinicalRiskManagement #VeterinaryClinicalPathology